Martin Peter Grobusch | Professor of Infectious Diseases & Global Health
Amsterdam UMC
Professor of Tropical Medicine and Traveller Medicine at the University of Amsterdam, Martin Peter Grobusch leads the Center for Tropical Medicine and Travel Medicine at Amsterdam UMC. A specialist in internal medicine, infectious diseases, and tropical medicine since 2000, he combines clinical care, research, and education in his work. Alongside his team, he provides comprehensive care for travellers — from pre-travel consultations to managing illnesses acquired abroad — while also mentoring young clinicians and overseeing research to advance new vaccines and treatments for tropical diseases such as malaria. His international career has spanned renowned institutions including the Charité University Medical Center (Berlin), the University of the Witwatersrand (Johannesburg), and the Institute of Tropical Medicine at the University of Tuebingen. His research focuses on malaria, tropical viral infections, tuberculosis, and the development of innovative interventions, and he works in partnership with clinical centres across Africa, Asia, and South America. He holds visiting and adjunct professorships in South Africa and Germany, directs research units in Gabon and Sierra Leone, and supervises PhD students from around the world. A recipient of the prestigious Eijkman Medal, he is a fellow of several international societies and plays a key role in global research consortia advancing tropical and infectious disease science.
Appearances:
Day 3 - Thursday 16th October @ 12:45
Combination Vaccines as Equity Accelerators: Can Co-Administration Ease the Burden on Health Systems?
- Exploring the scientific, clinical, and operational benefits of vaccine co-formulation for equity, efficacy, and broader protection – what diseases cluster geographically (e.g., schiso & dengue?)
- Challenges in developing compatible combination vaccines; ensuring immunogenic compatibility
- Case study: Measles/MPOX in Gaza, heat-stable malaria/hookworm combos, mRNA vaccine co-administration and implications for future NTD combinations
- Health system resilience, reducing immunisation burdens to enhance vaccine access in resource-limited settings
- Economic insights and equity considerations from LMIC perspective – how can combination vaccines cut delivery costs by 30-40%?
Day 3 - Thursday 16th October @ 13:45
Vaccine Policy in Polycrisis: Sustaining Immunisation Access Under Pressure
- Translating WHO guidelines into rapid, flexible decision-making
- Effective health system triage during chronic collapse
- Maintaining vaccine funding amid geopolitical disruptions: insights from EU budget cuts, US-Gulf state bridging finance, and UAE crisis funding mechanisms.
- Practical innovations in crisis vaccine delivery
- Accelerating R&D and policy adaptations under crisis conditions
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events